Arsanis, Inc. (NASDAQ:ASNS) Director Tillman U. Gerngross acquired 200,000 shares of Arsanis stock in a transaction on Monday, November 20th. The shares were bought at an average price of $10.00 per share, for a total transaction of $2,000,000.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Arsanis, Inc. (NASDAQ ASNS) opened at $15.18 on Wednesday. Arsanis, Inc. has a 52 week low of $12.48 and a 52 week high of $19.73.
TRADEMARK VIOLATION WARNING: This piece was published by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://stocknewstimes.com/2017/12/06/tillman-u-gerngross-acquires-200000-shares-of-arsanis-inc-asns-stock.html.
Arsanis, Inc is a biopharmaceutical company. The Company is focused on the discovering and developing monoclonal antibodies (mAbs) for the targeted immunotherapy of serious infections. The Company’s mAbs focus on specific pathogens and pathogenic processes. Its product pipeline includes ASN100, ASN200, ASN300, ASN400 and ASN500.
Receive News & Ratings for Arsanis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arsanis Inc. and related companies with MarketBeat.com's FREE daily email newsletter.